cell-care.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home : Cell |
| Description | The industry leader in scaled secretome Cell Care Therapeutics is a Los Angeles based preclinical stage biotech company developing biologics for the treatment of retinal |
| Keywords | secretome, mesenchymal, cell, stem cell, ophthalmology, diabetic retinopathy, macular degeneration, eye, biologic, biotech |
Server Information
| WebSite | |
| Host IP | 74.50.61.178 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cell-care.com Valuation
|
US$2,433,089
Last updated: 2023-05-08 05:01:30
cell-care.com has Semrush global rank of 4,350,151. cell-care.com has an estimated worth of US$ 2,433,089, based on its estimated Ads revenue. cell-care.com receives approximately 280,741 unique visitors each day. Its web server is located in United States, with IP address 74.50.61.178. According to SiteAdvisor, cell-care.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,433,089 |
| Daily Ads Revenue | US$2,246 |
| Monthly Ads Revenue | US$67,378 |
| Yearly Ads Revenue | US$808,535 |
| Daily Unique Visitors | 18,717 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cell-care.com. | A | 300 | IP: 74.50.61.178 |
| cell-care.com. | NS | 86400 | NS Record: ns-1084.awsdns-07.org. |
| cell-care.com. | NS | 86400 | NS Record: ns-1667.awsdns-16.co.uk. |
| cell-care.com. | NS | 86400 | NS Record: ns-400.awsdns-50.com. |
| cell-care.com. | NS | 86400 | NS Record: ns-770.awsdns-32.net. |
| cell-care.com. | MX | 300 | MX Record: 10 cellcare-com01b.mail.protection.outlook.com. |
| cell-care.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-08 05:01:30
| PLATFORM OUR FOCUS TEAM CONTACT NEWS CELL CARE THERAPEUTICS BIOLOGICS TO RESOLVE BLOOD VESSEL DEGENERATION AND INFLAMMATION Cell Care Therapeutics is developing a new class of biologics that are derived from the secreted proteins and exosomes of mesenchymal stromal cells (MSCs). The company’s novel secretome platform harnesses the signaling molecules of MSCs to promote the health of blood vessels and their surrounding tissue. The company is developing its first product for the treatment of diabetic macular edema, the leading cause of vision loss in working age adults. THE PLATFORM The industry leader in scaled secretome manufacturing It is increasingly recognized that the predominant therapeutic qualities of mesenchymal stromal cells come from the secretome, rather than from the cells themselves. Cell Care has developed a product engine to engineer and manufacture secretome based biologics that harness the therapeutic properties of mesenchymal stromal cells. OUR FOCUS Lead product |
HTTP Headers
HTTP/1.1 200 OK Server: nginx Date: Fri, 29 Oct 2021 10:17:53 GMT Content-Type: text/html Content-Length: 83089 Connection: keep-alive X-Accel-Version: 0.01 Last-Modified: Wed, 19 Feb 2020 18:26:02 GMT ETag: "14491-59ef1ebb37706" Accept-Ranges: bytes Vary: Accept-Encoding X-Powered-By: PleskLin |
cell-care.com Whois Information
Domain Name: CELL-CARE.COM Registry Domain ID: 1527377636_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2020-12-13T05:19:22Z Creation Date: 2008-11-06T19:06:16Z Registry Expiry Date: 2021-11-06T19:06:16Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: ok https://icann.org/epp#ok Name Server: NS-1084.AWSDNS-07.ORG Name Server: NS-1667.AWSDNS-16.CO.UK Name Server: NS-400.AWSDNS-50.COM Name Server: NS-770.AWSDNS-32.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T23:53:33Z <<< |